Idiopathic intracranial hypertension

Acta Neurologica Scandinavica

Volumn 121, Issue 2, 2010, Pages 71-82

  Dhungana, S ^a,c   Sharrack, B ^a   Woodroofe, N ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Idiopathic intracranial hypertension; Pathogenesis; Review

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; DANAZOL; FUROSEMIDE; GROWTH HORMONE; ISOTRETINOIN; LEPTIN; LITHIUM; NALIDIXIC ACID; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULFAMETHOXAZOLE; TETRACYCLINE; TOPIRAMATE;

BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID PRESSURE; CEREBROSPINAL FLUID SHUNTING; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FENESTRATION; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MAINTENANCE DRUG DOSE; MORBIDITY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OPTIC NERVE ATROPHY; OPTIMAL DRUG DOSE; PAPILLEDEMA; PATHOGENESIS; REVIEW; SINUS VENOSUS; STENOSIS; STENT; TREATMENT OUTCOME; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

HUMANS; PSEUDOTUMOR CEREBRI;

EID: 74349087779     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01172.x     Document Type: Review

References (136)

1. Quincke H. Über Meningitis serosa: Sammlung linische Vortra 67. Inn Med 1893 23 : 655 694.
2. Dandy WE. Intracranial pressure without brain tumour. Diagnosis and treatment. Ann Surg 1937 106 : 492 513.
3. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989 46 : 1049 1051.
4. Phillips PH, Repka MX, Lambert SR. Pseudotumour cerebri in children. J AAPOS 1998 2 : 33 8.
5. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumour cerebri population studies in Iowa and Louisiana. Arch Neurol 1988 45 : 875 877.
6. Radhakrishnan K, Thacker AK, Bohlega NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 1993 116 : 18 28.
7. Bono F, Messina D, Giliberto C et al. Bilateral transverse sinus stenosis predicts IIH without papiloedema in patients with migraine. Neurology 2006 67 : 419 423.
8. Rothner AD, Brust JC. Pseudotumor cerebri. Report of a familial occurrence. Arch Neurol 1974 30 : 110 111.
9. Traviesa DC, Schwartzman RJ, Glaser JS, Savino P. Familial benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1976 39 : 420 423.
10. Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology 1995 45 : 6 10.
11. Fujiwara S, Samamura Y, Kato T, Abe H, Katusima H. Idiopathic intracranial hypertension in female homozygous twins. J Neurol Neurosurg Psychiatry 1997 62 : 652 654.
12. Bedford THB. The effect of increased intracranial venous pressure on the pressure of the cerebrospinal fluid. Brain 1935 58 : 427 447.
13. Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981 15 : 168 174.
14. Johnston I, Hawke S, Halmagyi M, Teo C. The pseudotumor syndrome: disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly. Arch Neurol 1991 48 : 740 747.
15. Bono F, Giliberto C, Mastrandrea C et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 2005 65 : 1090 1093.
16. Higgins JN, Gillard JH, Owler BK, Harkness K, Pickard JD. MR venography in idiopathic intracranial hypertension: unappreciated and misunderstood. J Neurol Neurosurg Psychiatry 2004 75 : 621 625.
17. Rohr A, Dörner L, Stingele R et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. Am J Neuroradiol 2007 28 : 656 669.
18. Ayanzena RH, Bird CR, Kellera PJ, McCullya FJ, Theobalda MR, Heisermana JE. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. Am J Neuroradiol 2000 21 : 74 8.
19. Bono F, Lupo M, Lavano A et al. Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology 2003 61 : 1267 1270.
20. Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1954 6 : 791 803.
21. Bicakci K, Bicakci S, Aksungur E. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Acta Neurol Scand 2006 114 : 193 197.
22. Sorensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O. Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res 1989 11 : 160 164.
23. Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F, Henriksen O. Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. Am J Neuroradiol 1995 16 : 381 387.
24. Bastin ME, Sinha S, Farrall AJ, Wardlaw JM, Whittle IR. Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2003 74 : 1693 1696.
25. Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990 47 : 315 320.
26. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991 41 : 239 244.
27. Rowe FJ, Sarkies NJ. The relationship between obesity and idiopathic intracranial hypertension. Int J Obes Relat Metab Disord 1999 23 : 54 9.
28. Galvin JA, Van Stavern GP. Clinical characterization of idiopathic intracranial hypertension at Detroit Medical Centre. J Neurol Sci 2004 223 : 157 160.
29. Digre K, Corbett J. Pseudotumour cerebri in men. Arch Neurol 1998 45 : 866 872.
30. Kesler A, Goldhammer Y, Gadoth N. Do men with pseudotumor cerebri share the same characterstics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001 21 : 15 7.
31. Sugerman HJ, DeMaria EJ, Felton WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997 49 : 507 511.
32. Sinclair AJ, Ball AK, Burdon MA et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol 2008 201-202 : 202 220.
33. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation and atherogenesis. Endocrinology 2003 144 : 2195 2200.
34. Lampl Y, Eshel R, Kessler A. Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002 72 : 642 643.
35. Subramanian P, Goldenberg-Cohen N, Shukla S, Cheskin L, Miller N. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2004 138 : 109 113.
36. Ball AK, Sinclair AJ, Curnow SJ et al. Elevated CSF leptin in idiopathic intracranial hypertension: evidence for hypothalamic leptin resistance? Clin Endocrinol 2008 Sep 2 (Epup ahead of print).
37. Miller NL, Walsh FB, Newman NJ, Biousse V, Kerrison JB. Walsh and Hoyt's clinical neuro-ophthalmology: the essentials. Philadelphia, PA : Lippincott Williams & Wilkins, 2007 122 146.
38. Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome and thrombophilia. J Lab Clin Med 2005 145 : 72 82. (Pubitemid 40298732)
39. Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003 142 : 35 45.
40. Donaldson J, Horak E. Cerebrospinal fluid oestrone in pseudotumour cerebri. J Neurol Neurosurg Psychiatry 1982 45 : 734 736.
41. Toscano V, Sancesario G, Bianchi P, Cicardi C, Casilli D, Giacomini P. Cerebrospinal fluid estrone in pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J Endocrinol Invest 1991 14 : 81 6.
42. Soelberg P, Gjerris F, Svenstrup B. Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid. Arch Neurol 1986 43 : 902 906.
43. Glueck CJ, Goldenberg N, Golnik K, Sieve L, Ping W. Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men. Clin Appl Thromb Hemost 2005 11 : 441 448. (Pubitemid 41546771)
44. Sussman J, Leach M, Greaves M, Malia R, Davies-Jones GA. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997 62 : 229 233.
45. Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998 55 : 817 820.
46. Dunkley S, Johnston I. Thrombophilia as a common predisposing factor in pseudotumor cerebri. Blood 2004 103 : 1972 1973.
47. Backhouse O, Johnson M, Jamieson DR et al. Familial thrombophilia and idiopathic intracranial hypertension. Neuroophthalmology 2001 25 : 135 141. (Pubitemid 34025182)
48. Green L, Vinker S, Amital H, Amir T, Bar-Dayan Y, Levi Y. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995 25 : 103 108.
49. Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 2004 44 : 436 437.
50. Backhouse O, Metcalfe T, Goulding P, McEvoy M, Menage M. Factor V Leiden mutation in association with idiopathic intracranial hypertension. Br J Ophthalmol 1998 82 : 844.
51. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 2002 10 : 331 335.
52. Radhakrishnan K, Ahlskog E, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minnesota 1976-1990. Arch Neurol 1993 50 : 78 80.
53. Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980 55 : 541 546.
54. Wall M, George D. Idiopathic intracranial hypertension (pseudotumour cerebri), a prospective study of 50 patients. Brain 1991 114 : 155 180.
55. Corbett JJ, Savino PJ, Thompson HS et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from 5 to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982 39 : 461 474.
56. Marcelis J, Silberstein SD. Idiopathic intracranial hypertension without papilledema. Arch Neurol 1991 48 : 392 399.
57. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilloedema. A case control study in a headache centre. Neurology 1998 51 : 245 249.
58. Johnston I, Paterson A. Benign Intracranial Hypertension. II. CSF pressure and circulation. Brain 1974 97 : 301 312.
59. Wall M, Hart WM Jr., Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 1983 96 : 654 669.
60. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache 1997 37 : 286 288.
61. Kiwak KJ, Levine SE. Benign intracranial hypertension and facial diplegia. Arch Neurol 1984 41 : 787 788.
62. Speer C, Pearlman J, Phillips PH, Cooney M, Repka MX. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri. Am J Ophthalmol 1999 127 : 236 237.
63. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004 63 : 1737 1739.
64. Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008 70 : 634 640.
65. Rish BL, Meacham WF. Pseudotumor cerebri: a historical and clinical review. J Tenn Med Assoc 1965 58 : 355 361.
66. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002 59 : 1492 1495.
67. Farb RI, Vanek I, Scott JN et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003 60 : 1418 1424.
68. Higgins JN, Tipper G, Varley M, Pickard JD. Transverse sinus stenoses in benign intracranial hypertension demonstrated on CT venography. Br J Neurosurg 2005 19 : 137 140.
69. Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with psedutumour cerebri. Neurology 1983 33 : 1386 1388.
70. Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord 1995 19 : 762 763.
71. Wessel K, Thron A, Linden D, Petersen D, Dichgans J. Pseudotumor cerebri: clinical and neuroradiological findings. Eur Arch Psychiatry Neurol Sci 1987 237 : 54 60.
72. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998 105 : 1686 1693.
73. Lee AG, Brazis PW. Magnetic resonance venography in pseudotumour cerebri. J Neuroophthalmol 2000 20 : 12 3.
74. Alperin NJ, Lee SH, Loth F, Raksin PB, Lichtor T. MR-Intracranial pressure (ICP): a method to measure intracranial elastance and pressure non-invasively by means of MR imaging: baboon and human study. Radiology 2000 217 : 877 885.
75. Carlow TJ, Glaser JS. Pseudotumor cerebri syndrome in systemic lupus erythematosus. JAMA 1974 228 : 197 200.
76. Li EK, Ho PC. Pseudotumor cerebri in systemic lupus erythematosus. J Rheumatol 1989 16 : 113 116.
77. Padeh S, Passwell JH. Systemic lupus erythematosus presenting as idiopathic intracranial hypertension. J Rheumatol 1996 23 : 1266 1268.
78. Noetzel MJ, Rioux SD. Pseudotumor cerebri associated with obstructive nephropathy. Pediatr Neurol 1986 2 : 238 240.
79. Guy J, Johnston PK, Corbett JJ, Day AL, Glaser JS. Treatment of visual loss in pseudotumor cerebri associated with uraemia. Neurology 1990 40 : 28 32.
80. Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992 59 : 419 422.
81. Capriles LF. Intracranial hypertension and iron-deficiency anaemia. Arch Neurol 1963 9 : 147 153.
82. Condulis N, Germain G, Charest N, Levy S, Carpenter TO. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin Pediatr 1997 36 : 711 713.
83. Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after l-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997 130 : 478 480.
84. Campos SP, Olitsky S. Idiopathic intracranial hypertension after l-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr 1995 34 : 334 337.
85. Huseman CA, Torkelson RD. Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 1984 138 : 927 931.
86. Chiu AM, Chuenkongkaew WL, Cornblath WT et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998 126 : 116 121.
87. Giles C, Soble A. Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 1971 72 : 981 982.
88. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995 55 : 165 168.
89. Minutello JS, Dimayuga RG, Carter J. Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy: a case report. J Periodontol 1988 59 : 848 851.
90. Mochizuki K, Takahashi T, Kano M, Terajima K, Hori N. Pseudotumor cerebri induced by minocycline therapy or acne vulgaris. Jpn J Ophthalmol 2002 46 : 668 672.
91. Pierog SH, Al-Salihi FL, Cinotti D. Pseudotumor cerebri: a complication of tetracycline treatment of acne. J Adolesc Health Care 1986 7 : 139 140.
92. Cohen DN. Intracranial hypertension and papilledema associated with nalidixic acid. Am J Ophthalmol 1973 76 : 680 682.
93. Winrow AP, Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 1990 65 : 1165 1166.
94. Getenet JC, Croisile B, Vighetto A et al. Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurol Scand 1993 87 : 503 504.
95. Walsh FB, Clark DB, Thompson RS, Nicholson DH. Oral contraceptives and neuro-ophthalmologic interest. Arch Ophthalmol 1965 74 : 628 640.
96. Hamed LM, Glaser JS, Schatz NJ, Perez TH. Pseudotumor cerebri induced by danazol. Am J Ophthalmol 1989 107 : 105 110.
97. Sunku AJ, O'Duffy AE, Swanson JW. Benign intracranial hypertension associated with levonorgestrel implants. Ann Neurol 1993 34 : 299.
98. Levine SH, Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1990 51 : 251 253.
99. Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985 253 : 2869 2870.
100. Morrice G. Papilledema and hypervitaminosis A. JAMA 1970 213 : 1344.
101. Morrice G, Havener WH, Kapetanxky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 1960 173 : 1802 1805.
102. Roytman M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988 42 : 399 400.
103. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984 34 : 1509 1511.
104. Ch'ien LT. Intracranial hypertension and sulfamethoxazole. N Engl J Med 1976 283 : 47.
105. Neville BGR, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ 1970 3 : 554 556.
106. Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999 106 : 1186 1190.
107. Walters B, Gubbay S. In reply to: Hislop WS. Tetracycline and benign intracranial hypertension. Br Med J 1981 282 : 1240.
108. Newborg B. Pseudotumour cerebri treated by rice reduction diet. Arch Intern Med 1974 133 : 802 807.
109. Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998 50 : 1094 1098.
110. Amaral JF, Tsiaris W, Morgan T, Thompson WR. Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg 1987 122 : 946 949.
111. Sugerman HJ, Felton WL, Salvant JB, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 1995 45 : 1655 1659.
112. Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998 105 : 2313 2317.
113. Lubow M, Kuhr L. Pseudotumor cerebri: comments on practical management. Neuroophthalmology 1976 IX : 199 206.
114. Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuro-ophthalmol 1988 8 : 93 8.
115. Skau M, Brennum J, Gjerris F, Jensen R. What is knew about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2005 26 : 384 399.
116. Digre K. Idiopathic intracranial hypertension. Curr Treat Options Neurol 1999 1 : 74 81.
117. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000 41 (Suppl 1 S35 9.
118. Çelebisoy N, Gökçay F, Şirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand 2007 116 : 322 327.
119. Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumour cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994 117 : 352 357.
120. Zadik J, Barak Y, Stager D, Kaufman H, Ledith S, Gadoth N. Pseudotumour cerebri in a boy with 11-hydroxylase deficiency - a possible relation to rapid steroid withdrawal. Childs Nerv Syst 1985 1 : 179 181.
121. Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994 118 : 88 96.
122. Weisberg LA. Benign intracranial hypertension. Medicine 1975 54 : 197 207.
123. Kelman SE, Heaps R, Wolf A. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery 1992 30 : 391 395.
124. Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 1997 17 : 86 91.
125. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988 106 : 1378 1383.
126. Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumour cerebri. The lateral orbitotomy approach. Arch Ophthalmol 1988 106 : 1391 1397.
127. Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology 1993 100 : 683 690.
128. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996 46 : 1524 1530.
129. Johnston I, Besser M, Morgan MK. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988 69 : 195 202.
130. Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact Funct Neurosurg 2005 83 : 12 6.
131. Abu-Serieh B, Ghassempour K, Duprez T, Raftopoulos C. Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension. Neurosurgery 2007 60 : 1043 1044.
132. Rosenberg ML, Corbett JJ, Smith C et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993 43 : 1071 1072.
133. McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004 101 : 627 632.
134. Higgins JN, Cousins C, Owler BK, Sarkies N, Pickard JD. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 2003 74 : 1662 1666.
135. Donnet A, Metellus P, Levrier O et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology 2008 70 : 641 647.
136. Owler BK, Parker G, Halmagyi GM et al. Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J Neurosurg 2003 98 : 1045 1055.